Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 17

1.

Reversible parkinsonism and cognitive decline due to a possible interaction of valproic acid and quetiapine.

De Dios C, Fudio S, Lorenzo A.

J Clin Pharm Ther. 2011 Jun;36(3):430-2. doi: 10.1111/j.1365-2710.2010.01197.x.

PMID:
21545624
2.

Quetiapine for acute mania in bipolar disorder.

Brahm NC, Gutierres SL, Carnahan RM.

Am J Health Syst Pharm. 2007 May 15;64(10):1045-53. Review.

PMID:
17494904
3.
4.

[Therapeutic evidence for manic episode].

Terao T.

Seishin Shinkeigaku Zasshi. 2011;113(9):867-72. Review. Japanese.

PMID:
22117391
5.

[Clinical standing of valproate treatment of bipolar disorders].

Grunze H, Adli M, Bauer M, Berger M, Bergmann A, Bräunig P, Bschor T, Falkai P, Gastpar M, Greil W, Kasper S, Krüger S, Laux G, Müller WE, Naber D, Walden J.

Fortschr Neurol Psychiatr. 2007 Apr;75(4):220-35. Review. German.

PMID:
17427043
6.

Interactions between valproic acid and quetiapine/olanzapine in the treatment of bipolar disorder and the role of therapeutic drug monitoring.

Vella T, Mifsud J.

J Pharm Pharmacol. 2014 Jun;66(6):747-59. doi: 10.1111/jphp.12209. Review.

PMID:
24392714
7.

Does valproic acid warrant therapeutic drug monitoring in bipolar affective disorder?

Haymond J, Ensom MH.

Ther Drug Monit. 2010 Feb;32(1):19-29. doi: 10.1097/FTD.0b013e3181c13a30. Review.

PMID:
19901867
8.

[The influence of mood-normalizing agents on cognitive functions].

Suwalska A, Łojko D, Rybakowski J.

Psychiatr Pol. 2001 Mar-Apr;35(2):245-56. Review. Polish.

PMID:
11490889
9.

[Valproate in the treatment of bipolar disorder].

Rzewuska M.

Psychiatr Pol. 2002;36(2):239-57. Review. Polish.

PMID:
12043042
10.

Drug interactions of lithium and other antimanic/mood-stabilizing medications.

Dunner DL.

J Clin Psychiatry. 2003;64 Suppl 5:38-43. Review.

11.

A review of valproate in psychiatric practice.

Haddad PM, Das A, Ashfaq M, Wieck A.

Expert Opin Drug Metab Toxicol. 2009 May;5(5):539-51. doi: 10.1517/17425250902911455 . Review.

PMID:
19409030
12.

Outcome in the pharmacologic treatment of bipolar disorder.

Keck PE Jr, McElroy SL.

J Clin Psychopharmacol. 1996 Apr;16(2 Suppl 1):15S-23S. Review.

PMID:
8707996
13.

Pharmacokinetics, drug interactions, and tolerability of valproate.

DeVane CL.

Psychopharmacol Bull. 2003;37 Suppl 2:25-42. Review.

PMID:
14624231
14.

Latest therapies for bipolar disorder. Looking beyond lithium.

Goldberg JF, Citrome L.

Postgrad Med. 2005 Feb;117(2):25-6, 29-32, 35-6. Review.

PMID:
15745123
15.

[Therapy of bipolar affective illnesses with valproate. A review of the literature].

Retzow A, Emrich HM.

Psychiatr Prax. 1998 Jul;25(4):163-71. Review. German.

PMID:
9738242
16.

Current aspects of valproate in bipolar disorder.

Lennkh C, Simhandl C.

Int Clin Psychopharmacol. 2000 Jan;15(1):1-11. Review.

PMID:
10836280
17.

Valproic acid-induced parkinsonism in the elderly: a comprehensive review of the literature.

Mahmoud F, Tampi RR.

Am J Geriatr Pharmacother. 2011 Dec;9(6):405-12. doi: 10.1016/j.amjopharm.2011.09.002. Review.

PMID:
21993183
Items per page

Supplemental Content

Support Center